🇺🇸 FDA
Pipeline program

PV-10 (10% rose bengal disodium)

PV-10-MM-31

Phase 3 small_molecule terminated

Quick answer

PV-10 (10% rose bengal disodium) for Cutaneous Melanoma is a Phase 3 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PROVECTUS BIOPHARMACEUTICALS, INC.
Indication
Cutaneous Melanoma
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials